Advanced Practice Education Committee - Presentation Series 2025-2026 - 6/17/2026 Pharmacologic Management of Obstructive Hypertrophic Cardiomyopathy

RSSAAPACNE

Add to Calendar Advanced Practice Education Committee - Presentation Series 2025-2026 - 6/17/2026 Pharmacologic Management of Obstructive Hypertrophic Cardiomyopathy 6/17/2026 1:30:00 PM 6/17/2026 2:30:00 PM America/New_York For More Details: https://upenn.cloud-cme.com/course/courseoverview?EID=100458 Description: These are one-hour educational series that are presented by medical professionals who are experts in their respective fields. Topics include disease management, pharmacologic interventions, pathophysiology, and evidence-based practice. Objective(s): 1 Discuss the advantages and disadvantages associated with the use of guideline-directed medical therapy in patients with obstructive hypertrophic cardi... false MM/DD/YYYY


Wednesday, June 17, 2026, 1:30 PM - 2:30 PM


These are one-hour educational series that are presented by medical professionals who are experts in their respective fields. Topics include disease management, pharmacologic interventions, pathophysiology, and evidence-based practice.

Objective(s): 1 Discuss the advantages and disadvantages associated with the use of guideline-directed medical therapy in patients with obstructive hypertrophic cardiomyopathy 1 Discuss benefits and monitoring parameters required for an individual who qualifies for cardiac myosin inhibitors 2 Describe how a patient case is to select appropriate therapeutic strategies for obstructive hypertrophic cardiomyopathy
Location:
Specialties: ALL SPECIALTIES

Faculty Disclosures:
Tiffany Gardner, PharmD (Nothing to disclose - 06/04/2026)
Download Handout


Specialties - ALL SPECIALTIES


Objectives

After completing this activity, participants should be able to:


  1. Discuss the advantages and disadvantages associated with the use of guideline-directed medical therapy in patients with obstructive hypertrophic cardiomyopathy
  2. Discuss benefits and monitoring parameters required for an individual who qualifies for cardiac myosin inhibitors
  3. Describe how a patient case is to select appropriate therapeutic strategies for obstructive hypertrophic cardiomyopathy


In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Designation of Credit



AAPA (1.00 hours), NCPD Hours (ANCC) (1.00 hours), Non-Physician Attendance / Participation (1.00 hours)